Precision Biosciences (DTIL) Cash & Equivalents (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Precision Biosciences | 171.70 Mn | 70.52 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.33% |
| Dec 31, 2025 | 146.99% |
| Sep 30, 2025 | -27.91% |
| Jun 30, 2025 | -19.40% |
| Mar 31, 2025 | -10.10% |
| Dec 31, 2024 | -13.02% |
| Sep 30, 2024 | -20.08% |
| Jun 30, 2024 | -10.30% |
| Mar 31, 2024 | 18.07% |
| Dec 31, 2023 | -4.54% |
| Sep 30, 2023 | -11.29% |
| Jun 30, 2023 | -12.86% |
| Mar 31, 2023 | -16.59% |
| Dec 31, 2022 | -10.60% |
| Sep 30, 2022 | 15.16% |
| Jun 30, 2022 | 58.43% |
| Mar 31, 2022 | -19.10% |
| Dec 31, 2021 | -10.47% |
| Sep 30, 2021 | -7.75% |
| Jun 30, 2021 | -10.09% |
| Mar 31, 2021 | 115.44% |
| Dec 31, 2020 | -13.78% |
| Sep 30, 2020 | -17.92% |
| Jun 30, 2020 | -17.71% |
| Mar 31, 2020 | -14.76% |
| Dec 31, 2019 | -12.30% |
| Sep 30, 2019 | -8.77% |
| Jun 30, 2019 | 107.43% |
| Mar 31, 2019 | 5.63% |
| Jun 30, 2018 | 162.50% |